Navigation Links
Los Angeles Personal Injury Attorney Jeff Nadrich Responds to News that Johnson & Johnson Inadequately Assessed Metal Hip Dangers
Date:2/13/2013

Los Angeles, CA (PRWEB) February 13, 2013

New testimony from the ongoing DePuy ASR hip lawsuit* against Johnson & Johnson reveals that J&J may have severely underestimated the potential for failure in its Articular Surface Replacement, or A.S.R. implant, according to a new article from the New York Times. As the article outlines, a J&J internal review—conducted after the 2010 recall of the ASR—found that the company’s orthopedic unit “had used inadequate or incorrect standards in trying to assess some of those risks before first selling the implant in 2003.”

The report was introduced last week in Los Angeles Superior Court, in the first DePuy lawsuit to go to trial. More than 10,000 similar lawsuits have also been filed in the United States, all of them stemming from side effects and complications related to the ASR and other DePuy hip devices. The Times further points out that one of the company’s compliance managers—Jimmy Smith—was asked about the report, and confessed that company officials had not used appropriate engineering controls to try to anticipate the A.S.R’s potential problems. “They did their job, but they could have done it better,” Mr. Smith said.

The Times article further outlines that in a separate testimony, DePuy engineer Graham Isaac testified that before selling the A.S.R., the company only tested its performance on laboratory equipment at one angle of implantation. Orthopedic surgeons, however, can implant the artificial hip from a variety of angles.

Jeff Nadrich, a Los Angeles personal injury attorney and defective device lawyer, has been providing commentary about this case on his DePuy hip blog, and recently weighed in about these new revelations. According to Nadrich, “This trial has answered a lot of questions about how Johnson & Johnson was able to secure FDA approval for such a dangerous device, but it should also serve as an important lesson about the need for greater review and accountability for new drugs and devices.”

Nadrich further encourages other DePuy side effect victims to come forward and seek legal representation. “Johnson & Johnson has admitted that the company should have done more to foresee these problems, and patients should not be forced to suffer severe physical and financial consequences as a result.”

About Nadrich & Cohen: Jeffrey Nadrich is a personal injury attorney with Nadrich & Cohen, a California based law firm with offices in 18 locations across California. The firm has offices in Arcadia, Bakersfield, Fresno, Irvine, Long Beach, Modesto, Oakland, Oxnard, Palm Springs, Redding, Riverside, Sacramento, San Bernardino, San Diego, San Francisco, San Jose, Santa Rosa, and Tracy. Nadrich & Cohen handles all types of wrongful death and serious injury accident cases, including auto, truck, bus, motorcycle, and bicycle accidents, pedestrian collisions, boating accidents, dog bites, defective product cases and nursing home abuse. Victims are encouraged to call 1-800-718-4658 for a free consultation with a Nadrich & Cohen attorney.

  • Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court

Read the full story at http://www.prweb.com/releases/depuy-hip/att/prweb10406376.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Marina Aleksintser, Founder of BikiniMommyOnline & JNL Fitness Model Factory West Coast President, Brings the Hottest Method of Training to Los Angeles
2. Childhood Obesity Rates Drop in New York City, Los Angeles: Study
3. Three Surgeons of Los Angeles Colon and Rectal Surgical Associates Have Received the Prestigious 2013 Los Angeles SuperDoctors Award for the Second Year in a Row
4. US Drug Watchdog Now Expands Their All Metal Hip Implant Initiative By Inviting The Top Personal Injury Law Firms In All States To Help Them Get More Victims Indentified
5. TherapySites (Websites for Therapists) Announces Partnership with Personal Mood Chart Journal to Offer Website Marketing For Therapists
6. Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
7. Brightwater Senior Living of Stonebridge, Saskatoon's Newest Personal Care and Memory Care, Is Proud To Sponsor The Alzheimer Society of Saskatchewan's Walk For Memories
8. Personal epigenetic signatures found consistent in prostate cancer patients metastases
9. PMD Healthcare Announces that Spiro PD Personal Spirometer May Help Increase Flu Vaccination Rates as Epidemic Surges
10. Understanding personality for decision-making, longevity, and mental health
11. Fitness Celebrity and one of Canada’s Inside Fitness Hot and Fit Women of 2012, Nancy Di Nino, brings her Media Personality to host the Hot & Fit Release Party
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... School of Nursing with an in-kind gift of a VeinViewer® Vision vein ... as they learn how to start an IV and draw blood, combining technology ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi ... Management Solution Providers list for its expertise in eClinical Solutions. DDi has built ... serve the technology needs of global clients. DDi provides smarter technology for Clinical ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... , ... February 12, 2016 , ... As a former ... schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn to ... to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
(Date:2/11/2016)... (NasdaqCM: PDEX) today announced financial results for its fiscal 2016 ... its Quarterly Report on Form 10-Q for the second quarter ... today. --> --> Quarter ... --> Net sales for the three months ended December ... from $2.8 million for the three months ended December 31, ...
(Date:2/11/2016)...  Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... of pets, today announced the submission to FDA of ... Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline ... for the control of pyrexia (fever) in horses were ... --> The Chemistry, Manufacturing, and Controls ...
Breaking Medicine Technology: